Home/Pipeline/Pediatric Teledontics/Telegnathics Program

Pediatric Teledontics/Telegnathics Program

Pediatric Sleep-Disordered Breathing Prevention

CommercialActive

Key Facts

Indication
Pediatric Sleep-Disordered Breathing Prevention
Phase
Commercial
Status
Active
Company

About ApnoMed

ApnoMed is a U.S.-based medical technology company founded in 2008, operating at the intersection of respiratory health and dental sleep medicine. It has developed a proprietary platform and provider network to diagnose, manage, and treat airway disorders, with a strong emphasis on its ApnoDent® oral appliance and teledontic/telegnathic procedures. The company leverages over 20 years of clinical evidence, claims a 95% success rate, and differentiates itself through rigorous provider certification and a holistic, multidisciplinary care model. It appears to be a commercial-stage, private company generating revenue through its platform and provider services.

View full company profile